180 related articles for article (PubMed ID: 2913120)
1. Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation.
Herre JM; Sauve MJ; Malone P; Griffin JC; Helmy I; Langberg JJ; Goldberg H; Scheinman MM
J Am Coll Cardiol; 1989 Feb; 13(2):442-9. PubMed ID: 2913120
[TBL] [Abstract][Full Text] [Related]
2. Benefit and risks of long-term amiodarone therapy for sustained ventricular tachycardia/fibrillation: minimum of three-year follow-up in 145 patients.
Myers M; Peter T; Weiss D; Nalos PC; Gang ES; Oseran DS; Mandel WJ
Am Heart J; 1990 Jan; 119(1):8-14. PubMed ID: 2296879
[TBL] [Abstract][Full Text] [Related]
3. Amiodarone in patients with recurrent sustained ventricular tachyarrhythmias: results of programmed electrical stimulation and long-term clinical outcome in chronic treatment.
Schmitt C; Brachmann J; Waldecker B; Rizos I; Senges J; Kübler W
Am Heart J; 1987 Aug; 114(2):279-83. PubMed ID: 3604883
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment of ventricular tachycardia with amiodarone in presence of severe left ventricular dysfunction.
Burckhardt D; Robertson A; Hoffmann A; Pfisterer M
J Clin Pharmacol; 1991 Nov; 31(11):1105-8. PubMed ID: 1753016
[TBL] [Abstract][Full Text] [Related]
5. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
[TBL] [Abstract][Full Text] [Related]
6. Cardiac arrest and sudden death in patients treated with amiodarone for sustained ventricular tachycardia or ventricular fibrillation: risk stratification based on clinical variables.
DiCarlo LA; Morady F; Sauve MJ; Malone P; Davis JC; Evans-Bell T; Winston SA; Scheinman MM
Am J Cardiol; 1985 Feb; 55(4):372-4. PubMed ID: 3969871
[TBL] [Abstract][Full Text] [Related]
7. Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation.
Olson PJ; Woelfel A; Simpson RJ; Foster JR
Am J Cardiol; 1993 Apr; 71(10):823-6. PubMed ID: 8456761
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of postmyocardial infarction patients with ventricular tachycardia or ventricular fibrillation treated with amiodarone.
Strasberg B; Kusniec J; Zlotikamien B; Mager A; Sclarovsky S
Am J Cardiol; 1990 Sep; 66(7):673-8. PubMed ID: 2399883
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation.
Schützenberger W; Leisch F; Kerschner K; Harringer W; Herbinger W
Br Heart J; 1989 Nov; 62(5):367-71. PubMed ID: 2590589
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.
Heger JJ; Prystowsky EN; Jackman WM; Naccarelli GV; Warfel KA; Rinkenberger RL; Zipes DP
N Engl J Med; 1981 Sep; 305(10):539-45. PubMed ID: 6789201
[TBL] [Abstract][Full Text] [Related]
11. Risk stratification and prognosis of patients treated with amiodarone for malignant ventricular tachyarrhythmias after myocardial infarction.
Proclemer A; Facchin D; Vanuzzo D; Feruglio GA
Cardiovasc Drugs Ther; 1993 Aug; 7(4):683-9. PubMed ID: 8241012
[TBL] [Abstract][Full Text] [Related]
12. Intravenous amiodarone for short-term treatment of refractory ventricular tachycardia or fibrillation.
Nalos PC; Ismail Y; Pappas JM; Nyitray W; DonMichael TA
Am Heart J; 1991 Dec; 122(6):1629-32. PubMed ID: 1957758
[TBL] [Abstract][Full Text] [Related]
13. [Long-term results of treatment with oral amiodarone in patients with malignant ventricular arrhythmias].
Grande A; Farré J
Rev Esp Cardiol; 1987; 40(5):317-26. PubMed ID: 3454969
[No Abstract] [Full Text] [Related]
14. Long-term results of amiodarone therapy.
Herre JM; Sauve MJ; Scheinman MM
Clin Cardiol; 1987 Jul; 10(7 Suppl 1):I21-5. PubMed ID: 3271187
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
Heger JJ; Prystowsky EN; Zipes DP
Am Heart J; 1983 Oct; 106(4 Pt 2):887-94. PubMed ID: 6613835
[TBL] [Abstract][Full Text] [Related]
16. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias.
Anastasiou-Nana MI; Anderson JL; Nanas JN; Lutz JR; Smith RA; Anderson KP; Crapo RO; Call NB
Can J Cardiol; 1986; 2(3):138-45. PubMed ID: 2941121
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease.
Horowitz LN; Greenspan AM; Spielman SR; Webb CR; Morganroth J; Rotmensch H; Sokoloff NM; Rae AP; Segal BL; Kay HR
Am J Cardiol; 1985 Feb; 55(4):367-71. PubMed ID: 3969870
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of patients with ventricular tachycardia or fibrillation and a normal electrophysiologic study.
Kim SG; Aboaf AP; Roth J; Ferrick K; Fisher JD
Am Heart J; 1991 Jan; 121(1 Pt 1):77-80. PubMed ID: 1985381
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic efficacy of amiodarone in recurrent ventricular tachycardia evaluated by multiple electrophysiological and ambulatory ECG recordings.
Rasmussen K; Winkle R; Ross D; Griffin J; Peters F; Mason J
Acta Med Scand; 1982; 212(6):367-74. PubMed ID: 6760675
[TBL] [Abstract][Full Text] [Related]
20. [Empiric treatment with amiodarone in patients with sustained ventricular tachyarrhythmia. Results of a long-term follow-up].
Di Pede F; Raviele A; Gasparini G; Caprioglio F; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
G Ital Cardiol; 1990 Sep; 20(9):819-27. PubMed ID: 2079183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
